vimarsana.com

Page 47 - ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் நுஃபையீல்ட் துறை ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Date Time Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the UK’s PRINCIPLE trial in 1,779 participants. Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial.

Contact-Tracing Apps Flop in the US | Science

); //]]>// >By John P. Mello Jr. Dec 8, 2020 9:12 AM PT Despite the proven effectiveness of smartphone contact-tracing applications in reducing COVID-19 cases and deaths, Americans seem to have little interest in using the programs. An analysis by the Associated Press released Monday found that only 18 states make those apps available to their citizens and in those locales, only about one in 14 people have utilized the technology, which is used to identify people who have come into contact with a person infected with COVID-19. Adoption rates in areas using an app based on technology introduced by Google and Apple six months ago are higher, the AP noted, but even in the most successful of those states Connecticut only about 20 percent of residents have chosen to activate the software.

Contact-Tracing Apps Flop in the US

Dec 8, 2020 9:12 AM PT Despite the proven effectiveness of smartphone contact-tracing applications in reducing COVID-19 cases and deaths, Americans seem to have little interest in using the programs. An analysis by the Associated Press released Monday found that only 18 states make those apps available to their citizens and in those locales, only about one in 14 people have utilized the technology, which is used to identify people who have come into contact with a person infected with COVID-19. Adoption rates in areas using an app based on technology introduced by Google and Apple six months ago are higher, the AP noted, but even in the most successful of those states Connecticut only about 20 percent of residents have chosen to activate the software.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.